Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

In vivo Positron Emission Tomography Imaging Demonstrates Diminished Microglial Activation after Fingolimod Treatment in an Animal Model of Multiple Sclerosis.
Sex-specific control of CNS autoimmunity by p38 MAPK signaling in myeloid cells.
Time and time-frequency analysis of near-infrared signals for the assessment of ozone autohemotherapy long-term effects in multiple sclerosis.
Primary CNS lymphoma masquerading as tumefactive demyelination.
Management of disease modifying treatments in neurological autoimmune diseases of the central nervous system.
A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility.
Novel Kv1.3 blockers for immunosuppression: W02012155199.
MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database.
Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain.
Neuroantigen-Specific Autoregulatory CD8+ T Cells Inhibit Autoimmune Demyelination through Modulation of Dendritic Cell Function.
Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system.
Incorporating real-world clinical practice in multiple sclerosis economic evaluations.
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis.
MS as a gateway disease.
Improved MRI quantification of spinal cord atrophy in multiple sclerosis.
FDA warns about the risks of unproven surgical therapy for multiple sclerosis.
Activities-specific balance confidence in people with multiple sclerosis.
Functional connectivity analyses using emulated and conventional resting state data: Parts vs. the whole story.
Tailored balance exercises on people with multiple sclerosis: A pilot randomized, controlled study.
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.
Multiple sclerosis: IgM bands indicate reduced risk of PML on natalizumab.
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Probabilistic Multiple Sclerosis Lesion Classification based on Modelling Regional Intensity Variability and Local Neighbourhood Information.

Pages